These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27005852)

  • 1. The use of stable isotope-labeled drug as microtracers with conventional LC-MS/MS to support human absolute bioavailability studies: are we there yet?
    Ma S; Chowdhury SK
    Bioanalysis; 2016 Apr; 8(8):731-3. PubMed ID: 27005852
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming interference with the detection of a stable isotopically labeled microtracer in the evaluation of beclabuvir absolute bioavailability using a concomitant microtracer approach.
    Jiang H; Titsch C; Zeng J; Jones B; Joyce P; Gandhi Y; Turley W; Burrell R; Aubry AF; Arnold ME
    J Pharm Biomed Anal; 2017 Sep; 143():9-16. PubMed ID: 28544885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study.
    Yuan L; Huang C; Liu-Kreyche P; Voronin K; Fancher RM; Allentoff A; Zheng N; Iyer R; Zhu L; Pillutla R; Ji QC
    J Pharm Biomed Anal; 2019 Feb; 165():198-206. PubMed ID: 30553110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity-based analytical approaches to support human absolute bioavailability studies.
    Xu XS; Jiang H; Christopher LJ; Shen JX; Zeng J; Arnold ME
    Bioanalysis; 2014 Feb; 6(4):497-504. PubMed ID: 24568352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of matrix effects in LC-MS/MS bioanalysis.
    Bergeron A; Garofolo F
    Bioanalysis; 2013 Oct; 5(19):2331-2. PubMed ID: 24066616
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical strategies when using a stable isotope labeled microtracer for absolute bioavailability assessment: A case study of a high oral dose clinical candidate GDC-0810.
    Chen B; Lu P; Freeman D; Gao Y; Choo E; DeMent K; Savage S; Zhang K; Milanwoski D; Liu L; Dean B; Deng Y
    J Pharm Biomed Anal; 2018 May; 154():116-122. PubMed ID: 29549853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF.
    Can NÖ
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30029473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a liquid chromatography-isotope dilution tandem mass spectrometry for determination of olanzapine in human plasma and its application to bioavailability study.
    Zhang MQ; Jia JY; Lu C; Liu GY; Yu CY; Gui YZ; Liu Y; Liu YM; Wang W; Li SJ; Yu C
    Yao Xue Xue Bao; 2010 Jun; 45(6):767-71. PubMed ID: 20939188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the uncertainty of a quantitative approach to drug metabolites in the absence of authentic standards.
    Niwa M; Nakai N; Hosaka S; Ishii T; Mayumi T; Ueda A; Yamakawa T; Yasuda Y
    Bioanalysis; 2020 Jan; 12(1):7-10. PubMed ID: 31849265
    [No Abstract]   [Full Text] [Related]  

  • 11. Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry.
    Liang HR; Foltz RL; Meng M; Bennett P
    Rapid Commun Mass Spectrom; 2003; 17(24):2815-21. PubMed ID: 14673832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery.
    Kapinos B; Liu J; Piotrowski M; Keefer J; Holder B; Janiszewski J; Zhang H; Troutman M
    Bioanalysis; 2017 Nov; 9(21):1643-1654. PubMed ID: 29120233
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS.
    Rahavendran SV; Vekich S; Skor H; Batugo M; Nguyen L; Shetty B; Shen Z
    Bioanalysis; 2012 May; 4(9):1077-95. PubMed ID: 22612688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem mass spectrometry (LC-MS-MS): a predominant role in bioassays for pharmacokinetic studies.
    Marzo A; Bo LD
    Arzneimittelforschung; 2007; 57(2):122-8. PubMed ID: 17396623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.
    Gu H; Wang J; Aubry AF; Jiang H; Zeng J; Easter J; Wang JS; Dockens R; Bifano M; Burrell R; Arnold ME
    Anal Chem; 2012 Jun; 84(11):4844-50. PubMed ID: 22540405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a highly sensitive and selective novel trapping reagent, stable isotope labeled glutathione ethyl ester, for the detection of reactive metabolites.
    Yamaoka T; Kitamura Y
    J Pharmacol Toxicol Methods; 2015; 76():83-95. PubMed ID: 26314789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
    Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of resveratrol on the pharmacokinetic of ibrutinib by UPLC-MS/MS.
    Wen J; Bao SS; Zhang BW; Liu TH; Ou-Yang QG; Cai JP; Zhou HY
    Drug Dev Ind Pharm; 2019 Jan; 45(1):27-31. PubMed ID: 30156133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Separation of pharmaceutical compounds using high-performance liquid chromatography. Influence of water II. (author's transl)].
    Gonnet C; Rocca JL
    J Chromatogr; 1976 May; 120(2):419-33. PubMed ID: 1270558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of a novel Aurora-A (AurA) kinase AKI603 by UPLC-MS/MS and its application to a bioavailability study in rat.
    Zhao Z; Huang L; Gou X; Li Z; Chen J; Wen D; Jiang F; Lu G; Bi H; Huang M; Zhong G
    J Pharm Biomed Anal; 2016 Jun; 125():303-9. PubMed ID: 27070132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.